Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma Journal Article

   

Authors:	Moskowitz, A. J.; Yahalom, J.; Kewalramani, T.; Maragulia, J. C.; Vanak, J. M.; Zelenetz, A. D.; Moskowitz, C. H.
Article Title:	Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma
Abstract:	To identify prognostic factors for patients transplanted for relapsed or refractory Hodgkin lymphoma we carried out a combined analysis of patients followed prospectively on 3 consecutive protocols at Memorial Sloan-Kettering Cancer Center. One hundred fifty-three patients with chemosensitive disease after ICE (ifosfamide, carboplatin, and etoposide)-based salvage therapy (ST) proceeded to high-dose chemoradiotherapy followed by autologous stem cell transplantation (ASCT). Patients were evaluated with computed tomography and functional imaging (gallium or fluorodeoxyglucose-positron emission tomography) prior to ST and again before ASCT. Functional imaging status before ASCT was the only factor significant for event-free survival (EFS) and overall survival by multivariate analysis and clearly identifies poor risk patients (5-year EFS 31% and 75% for FI-positive and negative patients respectively). Administration of involved-field radiotherapy with ASCT was marginally significant for EFS (P = .055). Studies evaluating novel STs, conditioning regimens, post-ASCT maintenance, or allogeneic stem cell transplantation are warranted for patients who fail to normalize pre-ASCT functional imaging. © 2010 by The American Society of Hematology.
Keywords:	adolescent; adult; cancer survival; event free survival; human tissue; treatment outcome; aged; disease-free survival; middle aged; young adult; major clinical study; overall survival; salvage therapy; cancer combination chemotherapy; multimodality cancer therapy; cancer radiotherapy; combined modality therapy; outcome assessment; positron emission tomography; preoperative evaluation; prospective study; carboplatin; computer assisted tomography; neoplasm recurrence, local; etoposide; antineoplastic combined chemotherapy protocols; radiotherapy; relapse; tomography, x-ray computed; cyclophosphamide; autologous stem cell transplantation; hematopoietic stem cell transplantation; prediction; carmustine; ifosfamide; hodgkin disease; risk assessment; positron-emission tomography; transplantation conditioning; immunosuppressive treatment; transplantation, autologous; fluorodeoxyglucose; kaplan-meier estimate; gallium
Journal Title:	Blood
Volume:	116
Issue:	23
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2010-12-02
Start Page:	4934
End Page:	4937
Language:	English
DOI:	10.1182/blood-2010-05-282756
PUBMED:	20733154
PROVIDER:	scopus
PMCID:	PMC3799204
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-78649748606&partnerID=40&md5=a1d5315533eb7eee3377d87523178b49
Notes:	--- - "Cited By (since 1996): 2" - "Export Date: 20 April 2011" - "CODEN: BLOOA" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/4682